HLX07
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for HLX07, covering 2022-05-02 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer [Phase 2, Phase 3]